Mendus AB (CHIX:IMMUS) Buyback Yield %: -0.15 (As of Jul. 06, 2026)


CHIX:IMMUS Mendus AB CHIX:IMMUS
27 GF Score
Price kr32.70
! 2 Warning Signs
View Full Analysis

What is Mendus AB Buyback Yield %?

Mendus AB CHIX:IMMUS 27 Buyback Yield % is -0.15 as of Jul. 06, 2026. GuruFocus rates CHIX:IMMUS with a GF Score™ of 27/100. The stock has 2 warning signs investors should review. Among 741 Biotechnology companies, Mendus AB ranks better than 80.03% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Mendus AB's current buyback yield was -0.15%.

Mendus AB Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Mendus AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mendus AB Buyback Yield % Chart

Mendus AB Annual Data
Trend Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.91 0.00 -22.80 -4.20 -2.62

Mendus AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.51 0.00 0.00 -15.30 -0.20

CHIX:IMMUS vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Mendus AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mendus AB Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mendus AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Mendus AB's Buyback Yield % falls into.


CHIX:IMMUS
27GF Score
Mendus AB CHIX:IMMUS
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mendus AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Mendus AB's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-1.725 + 54.225) / 2003.9541
=-2.62%

Mendus AB's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-1.725 + 2.27) / 2003.9541
=-0.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -0.15 mean?
Mendus AB (CHIX:IMMUS) has a Buyback Yield % of -0.15 as of Jul. 06, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Mendus AB and its competitors. According to the industry distribution chart, Mendus AB ranks #148 out of 741 companies in the Biotechnology industry, placing it in the top 20%.
Is Mendus AB's Buyback Yield % too high?
Mendus AB's current Buyback Yield % is -0.15. Based on the distribution chart, Mendus AB ranks #148 out of 741 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Mendus AB has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Mendus AB's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Mendus AB ranks #148 out of 741 companies for Buyback Yield %. This places Mendus AB in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Mendus AB and its competitors. Mendus AB's current Buyback Yield % is -0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mendus AB stock overvalued right now?
Mendus AB (CHIX:IMMUS) has a current Buyback Yield % of -0.15. The current Buyback Yield % is -0.15. Mendus AB's overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Mendus AB (CHIX:IMMUS), the current Buyback Yield % is -0.15 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mendus AB Business Description

Other Exchanges IMMU:Sweden1YG0:Germany
Address Vastra Tradgardsgatan 15, Stockholm, SWE, 11153
Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals. The company's Pipeline includes: Vididencel, and Ilixadencel.
27GF Score

Get the complete analysis for CHIX:IMMUS

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr32.70
Price